Menu
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • MRI Phantoms
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
  • FAST Login
  • Easy Setup
  • Find a Centre
  • SMART Portal
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • MRI Phantoms
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
Home | Investors | ASX Announcements | 2010

ASX Announcements 2010

Date Document
20/12/2010 Securities Trading Policy
17/12/2010 Board Changes
22/11/2010 Change of Director`s Interest Notice
22/11/2010 Appendix 3B
17/11/2010 Results of Annual General Meeting
17/11/2010 Resonance Health Announces new FerriScan contracts
17/11/2010 AGM Presentation to Shareholders
29/10/2010 Appendix 4C - quarterly
13/10/2010 Annual Report to shareholders
13/10/2010 Notice of Annual General Meeting/Proxy Form
06/10/2010 Resonance Health Announces Agreement with Novartis
29/09/2010 Financial Report
30/08/2010 Preliminary Final Report
30/07/2010 Appendix 4C - quarterly
28/07/2010 Liver Fibrosis and Fat Test Update
15/06/2010 FerriScan selected for the UK Choose and Book System for GPs
09/06/2010 First International Distributor for FerriScan
24/05/2010 Investor Newsletter
07/05/2010 Resonance Health Fibrosis Results
30/04/2010 Appendix 4C - quarterly
01/04/2010 Fibrosis Test Update
19/03/2010 Resonance Health launches MRI Cardiac Test
22/02/2010 Half Yearly Report and Accounts
29/01/2010 Appendix 4C - quarterly

 

Investors

  • Business Overview
  • Board and Management Team
  • Share Price
  • ASX Announcements
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
  • ASX subscribe
  • Annual Reports
  • Analyst Coverage
  • Twitter
  • LinkedIn
  • Search
  • © 2018 Resonance Health
  • Disclaimer
  • Privacy
  • Sitemap
Website by ChooseDigital.com.au